IngentaConnect Proton pump inhibitor modifies inflammatory reaction in human gas...

Authors: Suzuki, M.¹; Suzuki, H.²; Kitahora, T.³; Miyazawa, M.¹; Nagahashi, S.²; Suzuki, K.¹; Ishii, H.²

Source: Alimentary Pharmacology & Therapeutics, Volume 16, Supplement 2, April 2002 , pp. 229-234(6)

Abstract:

Aim:

To examine whether proton pump inhibitors modify the production of oxygen-derived free radicals and related cytokines in the human gastric mucosa infected with H. pylori. Methods:

Thirty-four H. pylori-positive peptic ulcer patients (23 gastric ulcer, 11 duodenal ulcer) were enrolled. Biopsy tissue samples were obtained endoscopically from the antrum and corpus. Tissue content of neutrophil myeloperoxidase (myeloperoxidase) and IL-8 was measured by ELISA. Mucosal production of oxygen-derived free radical was measured using luminol-dependent chemiluminescence (ChL). A proton pump inhibitor (either lansoprazole 30 mg, omeprazole 20 mg, or rabeprazole 10 mg) was administered daily by mouth to all patients for 8 weeks. Endoscopic examination was then repeated, and biochemical analysis was performed. Results:

Antral myeloperoxidase decreased significantly after proton pump inhibitor treatment (5.23 ± 7.00-2.76 ± 5.11 ng/mg, P < 0.02), but corpus myeloperoxidase was unchanged. IL-8 was also modified by proton pump inhibitors and these changes were parallel to those of myeloperoxidase. Corpus ChL was significantly increased from 88.5 ± 69.8-159 ± 172 counts/10 s/mg after proton pump inhibitor treatment, whereas antrum ChL was not altered. H. pylori infection rate was decreased in the antrum as well as the corpus. Conclusions:

Proton pump inhibitor treatment stimulated oxygen-derived free radical production in the corpus mucosa.

Document Type: Research article

DOI: 10.1046/j.1365-2036.16.s2.19.x

Affiliations: 1: Division of Gastroenterology, National Tokyo Medical Center, Tokyo, Japan, 2: Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan, 3: Division of Gastroenterology, National Okura Hospital, Tokyo, Japan

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Proton pump inhibitor modifies inflammatory reaction in human gastric mucosa infected by Helicobacter pylori